sST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trial.

Smadja DM, Massonnaud CR, Philippe A, Rosa M, Luneau S, Rauch A, Peiffer-Smadja N, Gagneux-Brunon A, Poissy J, Gruest M, Ung A, Pourcher V, Raffi F, Piroth L, Bouiller K, Esperou H, Delmas C, Belhadi D, Diallo A, Saillard J, Dechanet A, Mercier N, Dupont A, Lescure FX, Goehringer F, Jaureguiberry S, Danion F, Tolsma V, Cabie A, Courjon J, Leroy S, Mootien J, Mourvillier B, Gallien S, Lanoix JP, Botelho-Nevers E, Wallet F, Richard JC, Reuter J, Gaymard A, Greil R, Martin-Blondel G, Andrejak C, Yazdanpanah Y, Burdet C, Diehl JL, Hites M, Ader F, Susen S, Mentré F, Dupont A, Discovery Study Group

Open source

DOI
10.1038/s41598-025-95122-7
Published
2025 Apr 24
Container
Scientific reports
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-025-95122-7,
  title = {sST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trial.},
  author = {Smadja DM and Massonnaud CR and Philippe A and Rosa M and Luneau S and Rauch A and Peiffer-Smadja N and Gagneux-Brunon A and Poissy J and Gruest M and Ung A and Pourcher V and Raffi F and Piroth L and Bouiller K and Esperou H and Delmas C and Belhadi D and Diallo A and Saillard J and Dechanet A and Mercier N and Dupont A and Lescure FX and Goehringer F and Jaureguiberry S and Danion F and Tolsma V and Cabie A and Courjon J and Leroy S and Mootien J and Mourvillier B and Gallien S and Lanoix JP and Botelho-Nevers E and Wallet F and Richard JC and Reuter J and Gaymard A and Greil R and Martin-Blondel G and Andrejak C and Yazdanpanah Y and Burdet C and Diehl JL and Hites M and Ader F and Susen S and Mentré F and Dupont A and Discovery Study Group},
  year = {2025},
  journal = {Scientific reports},
  doi = {10.1038/s41598-025-95122-7},
  url = {https://doi.org/10.1038/s41598-025-95122-7}
}

RIS

TY  - JOUR
TI  - sST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trial.
AU  - Smadja DM
AU  - Massonnaud CR
AU  - Philippe A
AU  - Rosa M
AU  - Luneau S
AU  - Rauch A
AU  - Peiffer-Smadja N
AU  - Gagneux-Brunon A
AU  - Poissy J
AU  - Gruest M
AU  - Ung A
AU  - Pourcher V
AU  - Raffi F
AU  - Piroth L
AU  - Bouiller K
AU  - Esperou H
AU  - Delmas C
AU  - Belhadi D
AU  - Diallo A
AU  - Saillard J
AU  - Dechanet A
AU  - Mercier N
AU  - Dupont A
AU  - Lescure FX
AU  - Goehringer F
AU  - Jaureguiberry S
AU  - Danion F
AU  - Tolsma V
AU  - Cabie A
AU  - Courjon J
AU  - Leroy S
AU  - Mootien J
AU  - Mourvillier B
AU  - Gallien S
AU  - Lanoix JP
AU  - Botelho-Nevers E
AU  - Wallet F
AU  - Richard JC
AU  - Reuter J
AU  - Gaymard A
AU  - Greil R
AU  - Martin-Blondel G
AU  - Andrejak C
AU  - Yazdanpanah Y
AU  - Burdet C
AU  - Diehl JL
AU  - Hites M
AU  - Ader F
AU  - Susen S
AU  - Mentré F
AU  - Dupont A
AU  - Discovery Study Group
PY  - 2025
JO  - Scientific reports
DO  - 10.1038/s41598-025-95122-7
UR  - https://doi.org/10.1038/s41598-025-95122-7
ER  -

APA

DM, S., CR, M., A, P., M, R., S, L., A, R., N, P., A, G., J, P., M, G., A, U., V, P., F, R., L, P., K, B., H, E., C, D., D, B., A, D., J, S., A, D., N, M., A, D., FX, L., F, G., S, J., F, D., V, T., A, C., J, C., S, L., J, M., B, M., S, G., JP, L., E, B., F, W., JC, R., J, R., A, G., R, G., G, M., C, A., Y, Y., C, B., JL, D., M, H., F, A., S, S., F, M., A, D., & Group, D. S. (2025). sST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trial.. Scientific reports. https://doi.org/10.1038/s41598-025-95122-7

Source records